Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Design Therapeutics (DSGN) Q2 2026 Earnings
DSGN
28
Apr
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.34
-0.32
-0.3
-0.28
Details
Expected EPS
-0.328333
Actual EPS
-0.29
Surprise EPS
0.04
Surprise Percent
+11.68%
Description
Design Therapeutics (DSGN) has reported earnings of -0.29 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login